CRDO:NASDAQCredo Technology Group Holding Ltd Analysis
Data as of 2026-08-24 - not real-time
$230.57
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Credo Technology Group Holding Ltd trades at $230.57, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 10.6% over the past 30 days. Relative strength is 47.7 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $177.00 and resistance at $286.24.
Valuation screens as overvalued: a P/E of 91.9 sits above the sector average of 35.2. Analyst price targets sit 22.8% above the current price. Revenue is growing at 157.0% on a 35.4% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 103.4%, a beta of 3.31 and a maximum drawdown of 53.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Valuation screens as overvalued: a P/E of 91.9 sits above the sector average of 35.2. Analyst price targets sit 22.8% above the current price. Revenue is growing at 157.0% on a 35.4% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 103.4%, a beta of 3.31 and a maximum drawdown of 53.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
Polen Capital, an investment management company, released its second-quarter 2026 investor letter for “Polen...Deep Sail Capital Partners, an investment management company, released its first-quarter 2026 investor letter.Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second-quarter...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 172.87
- MACD momentum is negative
- 30-day price change of -10.6%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 91.9 versus sector average of 35.2
- Trading above the 200-day average of 172.87
- Analyst targets imply +22.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 91.9 versus sector average of 35.2
- Analyst targets imply +22.8% versus the current price
- Profit margin of 35.4% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth157.00%
Profit Margin35.37%
P/E Ratio91.9
ROE34.41%
ROA17.92%
Debt/Equity1.23
P/B Ratio20.7
Op. Cash Flow$464.3M
Free Cash Flow$250.8M
Industry P/E35.2
Technical Analysis
TrendNeutral
RSI47.7
Support$177.00
Resistance$286.24
MA 20$232.72
MA 50$241.52
MA 200$172.87
MACDBearish
VolumeDecreasing
Fear & Greed Index93.05
Valuation
Fair Value$54.58
Target Price$283.23
Upside/Downside22.84%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.31
Volatility103.41%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.